A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.

scientific article published in October 2014

A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/DMRR.2543
P698PubMed publication ID24638886

P50authorMark NivenQ43176444
P2093author name stringMichael Belkin
Efrat Assa-Kunik
Galit Sivak
Itschak Lamensdorf
Michael Krakovsky
Revital Duvdevani
Shlomo Bulvik
Yael Porat
P2860cites workSafety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular deliveryQ44576144
Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroidsQ45142883
Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.Q45514281
Cutting edge: proangiogenic properties of alternatively activated dendritic cells.Q46664069
Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathyQ49060256
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.Q50981942
Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes StudyQ72571573
Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cellsQ73521253
Dendritic cell activation kinetics and cancer immunotherapyQ76378365
Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineagesQ79276435
Intramyocardial angiogenic cell precursor injection for cardiomyopathyQ80996340
Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisalQ82991530
Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10Q83181554
Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effectQ24635138
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activationQ24677534
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distributionQ24679240
Dendritic cells and the control of immunityQ27860918
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaQ28251443
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research GroupQ28261623
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationQ29547453
Immunobiology of dendritic cellsQ29547465
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat heartsQ29620480
High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis.Q33232238
Quantitative analysis of peripheral tissue perfusion using spatiotemporal molecular dynamicsQ33402912
Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporationQ33555860
Critical limb ischemiaQ33814176
Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular diseaseQ34051561
Immature, but not inactive: the tolerogenic function of immature dendritic cellsQ34842360
Some interfaces of dendritic cell biologyQ35219290
Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligandsQ35578604
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responsesQ35582560
Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapyQ36055845
Proliferating dendritic cell progenitors in human bloodQ36363279
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell toleranceQ36376611
Dendritic cells and cytokines in human inflammatory and autoimmune diseasesQ36699918
Dendritic cell-endothelial cell cross-talk in angiogenesisQ36907764
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literatureQ37594251
Functional CD40 on B lymphocytes and dendritic cellsQ40395371
The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunityQ40614146
Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trialsQ40660723
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Role of dendritic cells in cardiovascular diseasesQ41332123
The dendritic cell lineage in haemopoiesisQ41348648
Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosisQ41940674
The prevalence of peripheral arterial disease in a defined populationQ43564702
Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.Q43808485
P433issue7
P304page(s)623-634
P577publication date2014-10-01
P1433published inDiabetes - Metabolism: Research and ReviewsQ15750056
P1476titleA novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.
P478volume30